Literature DB >> 17498530

Ductal carcinoma in situ--current management.

Martin J O'Sullivan1, Monica Morrow.   

Abstract

This article summarizes the modern evidence-based management of ductal carcinoma in situ. The data addressing the surgical issues, including indications for mastectomy and the use of sentinel node biopsy, are presented. The randomized trials examining the role of radiation therapy after breast-conserving surgery and the use of tamoxifen in ductal carcinoma in situ are discussed. Factors to consider in developing a management strategy for the individual patient are elucidated in the final section.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17498530     DOI: 10.1016/j.suc.2007.01.006

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  4 in total

1.  Co-Expression of p16, Ki67 and COX-2 Is Associated with Basal Phenotype in High-Grade Ductal Carcinoma In Situ of the Breast.

Authors:  Amanda Arantes Perez; Débora Balabram; Rafael Malagoli Rocha; Átila da Silva Souza; Helenice Gobbi
Journal:  J Histochem Cytochem       Date:  2015-02-23       Impact factor: 2.479

Review 2.  Ductal carcinoma in situ: terminology, classification, and natural history.

Authors:  D Craig Allred
Journal:  J Natl Cancer Inst Monogr       Date:  2010

3.  Development and Validation of the BREAST-Q Breast-Conserving Therapy Module.

Authors:  Anne F Klassen; Laura Dominici; Sarah Fuzesi; Stefan J Cano; Dunya Atisha; Tracie Locklear; Madelijn L Gregorowitsch; Elena Tsangaris; Monica Morrow; Tari King; Andrea L Pusic
Journal:  Ann Surg Oncol       Date:  2020-01-21       Impact factor: 5.344

4.  Immunohistochemical profile of high-grade ductal carcinoma in situ of the breast.

Authors:  Amanda Arantes Perez; Rafael Malagoli Rocha; Débora Balabram; Átila da Silva Souza; Helenice Gobbi
Journal:  Clinics (Sao Paulo)       Date:  2013-05       Impact factor: 2.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.